These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20455258)

  • 1. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.
    Nagji AS; Liu Y; Stelow EB; Stukenborg GJ; Jones DR
    J Pathol; 2010 Jun; 221(2):229-37. PubMed ID: 20455258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
    Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients.
    Yang J; Shen Y; Liu B; Tong Y
    Lung Cancer; 2011 Nov; 74(2):305-9. PubMed ID: 21726917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
    Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Up-regulation of DLK1 in non-small cell lung cancer and the relevant molecular mechanism].
    Zhang SS; Tan JJ; Li L; Chen WT; Han NJ; Guo SP; Zheng S; Liu Y; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):510-4. PubMed ID: 27531264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
    Smith PW; Liu Y; Siefert SA; Moskaluk CA; Petroni GR; Jones DR
    Cancer Lett; 2009 Apr; 276(2):196-203. PubMed ID: 19111386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of expression of BRMS1 gene protein and the expression of BRMS1 gene promotor area methylation in supraglottic laryngeal carcinoma and its clinical significance].
    Li X; Wu Y; Sun Y; Huang M; Ma D; Xu J; Guo X; Jiang X; Guan C; Li F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(15):701-3. PubMed ID: 23167184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
    Metge BJ; Frost AR; King JA; Dyess DL; Welch DR; Samant RS; Shevde LA
    Clin Exp Metastasis; 2008; 25(7):753-63. PubMed ID: 18566899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.
    Liu Y; Mayo MW; Nagji AS; Smith PW; Ramsey CS; Li D; Jones DR
    Oncogene; 2012 Mar; 31(9):1143-54. PubMed ID: 21765477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
    Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.
    Chimonidou M; Kallergi G; Georgoulias V; Welch DR; Lianidou ES
    Mol Cancer Res; 2013 Oct; 11(10):1248-57. PubMed ID: 23744981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
    Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
    [No Abstract]   [Full Text] [Related]  

  • 16. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
    Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JE; Lee SY; Park JY
    Lung Cancer; 2009 Aug; 65(2):247-50. PubMed ID: 19362748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
    Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S
    Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
    Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.